Monday, 20 May 2019

India News

  • Dr. Reddy's launches Aricept generic Donepezil

    India |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generic version of Aricept, 23 mg in the US market following the approval b...Read more

  • Non-invasive device to assess liver fibrosis

    India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Singapore: In the run up to World Hepatitis Day, to be commemorated on July 28, one of the main goals globally is to raise awareness about viral hepatitis and its causes. Despite its stagge...Read more

  • Lupin gets FDA nod for Suprax oral suspension

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Mumbai: Lupin subsidiary, Lupin Pharmaceuticals, received approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL from the US FDA. Lupin expects to commence shipping of the product ...Read more

  • BioCOS rides on established R&D protocols

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

    The affordable and personalized healthcare has been a major concern worldwide. The big pharma and diagnostic companies are now realizing the strong impact of efficient computational methods...Read more

  • APAC healthcare industry becomes cloud friendly

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Varian's device gets nod from Indian atomic board

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: US-based Varian Medical Systems has received regulatory clearance from Indian Atomic Energy Regulatory Board for the use of its TrueBeam High Intensity Mode for advanced radiosur...Read more

  • Stanford Univ, DBT India program is a big hit'

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Dr Rajiv Doshi, executive director (US), Stanford-India Biodesign (SIB), and consulting assistant professor, Stanford University, US, was one of the many eminent individuals who attended th...Read more

  • Has collaborative commercialization arrived in India?

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Faced with many uncertainties after the introduction of a series of reforms from the 1990s, both Indian and foreign firms have closely followed the growth of the pharmaceutical industry. Lo...Read more

  • Top 20 APAC Country Analysis: Korea

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2015

    Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Ministry of Food and Drug Safety (MFDS) stated that medicine exports of th...Read more

  • Lupin gets FDA nod for anti-depression generic

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Mumbai: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals has received final approval for its Escitalopram tablets (Escitalopram oxalate) 5mg, 10mg, and 20mg, from t...Read more

  • A time to rethink talent management

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • ABLE, BioTecNika join hands to develop industry-academy collaboration

    India |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Singapore: BioTecNika, India's biotechnolgy professional network has joined hands with ABLE - Association of Biotech led enterprises, to develop speedy collaboration between academia and in...Read more

  • Bangalore Bio: Regulation must enable progress

    India |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2013

    Bangalore: Day two of India's premier biotech event, Bangalore India Bio 2013, saw several eminent individuals discuss on the topic of 'Biosimilar guidelines for development of safe, afford...Read more

  • Frost & Sullivan awards life science leaders

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Mumbai: The 4th Annual Frost & Sullivan India Healthcare Excellence Awards 2012, were held in Mumbai to recognize companies that showed innovative growth strategies and solutions in the...Read more

  • New strategy tests for active TB stage in Asia

    India |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2013

    Singapore: More than 20,000 people in Pakistan are being tested for the potentially deadly stage of tuberculosis using a new strategy developed at UC Davis Health System, US, to effectively...Read more

  • Ranbaxy may fire 1/3rd of its global sales staff

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of the job cuts expected to be in the US, according to a report by Busi...Read more

  • Mazumdar Shaw in Forbes most powerful woman list

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

    Bangalore: Dr Kiran Mazumdar Shaw, chairman and managing director, Biocon, has been ranked 80th on Forbes' list of the most powerful women in the world. The list, which is published on an a...Read more

  • Hiring freeze in pharma industry

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

    New Delhi: The overall economic crunch has resulted in companies adopting a cautious approach in their hiring plans. Naukri.com, a major job site in India, in its survey on the pharma secto...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls